MCM6 is a Poor Prognostic Biomarker and Promotes Progression in Breast Cancer

Background: Breast cancer is the commonest global malignancy and the primary cause of carcinoma death. MCM6 is vital to carcinogenesis, but the pathogenesis of MCM6 remains unclear. Methods: MCM6 expression in patients with breast cancer was examined through The Cancer Genome Atlas (TCGA) database,...

Descripció completa

Dades bibliogràfiques

Autors principals:	Zi Lei, Peng Wang, Da-qi Jia, Lei-lei Li, Yi-peng Wu, Yuan Yang, Guo-qing Pan
Format:	Artigo
Idioma:	Inglês
Publicat:	IMR Press 2023-08-01
Col·lecció:	Frontiers in Bioscience-Landmark
Matèries:	breast cancer mcm6 prognosis nomogram drug sensitivity immune cell
Accés en línia:	https://www.imrpress.com/journal/FBL/28/8/10.31083/j.fbl2808188
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!